Bausch Health Companies Inc expected to post earnings of $1.19 a share - Earnings Preview

Bausch Health Companies

17/02/2025 21:30

* Bausch Health Companies Inc  BHC.TO   is expected to show
a rise
in quarterly revenue when it reports  results on February 19 for
the period ending December 31 2024
    * The Laval Quebec-based  company is expected to report a
4.8% increase in revenue to $2.524 billion from $2.41 billion a
year ago, according to the mean estimate from 4 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Bausch Health Companies
Inc is
for earnings of $1.19 per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bausch
Health
Companies Inc is $9.75​, above​ its last closing price
of C$8.73. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  1.04        1.06       1.13      Beat    7
 Jun. 30 2024  0.87        0.88       0.89      Beat    1.5
 Mar. 31 2024  0.73        0.72       0.60      Missed  -16.4​
 Dec. 31 2023  1.01        1.00       1.15      Beat    14.5
 ​​Sep.        0.92        0.90       1.02      Beat    13.9
 30 2023                                                
 Jun. 30 2023  0.76        0.76       0.82      Beat    7.6​
 Mar. 31 2023  0.73        0.72       0.52      Missed  -27.6
 Dec. 31 2022  0.92        0.91       1.03      Beat    13.7
 This summary was machine generated February 17 at 21:30 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)